Please login to the form below

Not currently logged in
Email:
Password:

Revolade

This page shows the latest Revolade news and features for those working in and with pharma, biotech and healthcare.

FDA clears Dova drug for liver-related low blood platelets

FDA clears Dova drug for liver-related low blood platelets

FDA clears Dova drug for liver-related low blood platelets. Drug is in the same class as Novartis’Promacta/Revolade. ... Doptelet is in the same class as Novartis’ Promacta/Revolade (eltrombopag), originally developed by GlaxoSmithKline, which is

Latest news

More from news
Approximately 8 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics